OOIR: Observatory of International Research

Papers

(The median citation count of JACC-Cardiovascular Interventions is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
3-Year Outcomes of the ULTIMATE Trial Comparing Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation	180
Indigo Aspiration System for Treatment of Pulmonary Embolism	173
Incidence, Predictors, and Implications of Permanent Pacemaker Requirement After Transcatheter Aortic Valve Replacement	139
Transfemoral Transcatheter Tricuspid Valve Replacement With the EVOQUE System	129
Coronary Cannulation After Transcatheter Aortic Valve Replacement	128
ACTIVATION (PercutAneous Coronary inTervention prIor to transcatheter aortic VAlve implantaTION)	126
Effect of CYP2C19 Genotype on Ischemic Outcomes During Oral P2Y12 Inhibitor Therapy	112
Drug-Coated Balloon Versus Drug-Eluting Stent for Small Coronary Vessel Disease	108
Distal Radial Artery Approach to Prevent Radial Artery Occlusion Trial	105
Principles of Intravascular Lithotripsy for Calcific Plaque Modification	97
Randomized Trial Comparing Standard Versus Ultrasound-Assisted Thrombolysis for Submassive Pulmonary Embolism	97
Valve-in-Valve Transcatheter Aortic Valve Replacement Versus Redo Surgical Aortic Valve Replacement	94
Intravascular Lithotripsy for Treatment of Calcified Coronary Lesions	89
Intravascular Lithotripsy for Peripheral Artery Calcification	84
Randomized Comparison of Transcatheter Edge-to-Edge Repair for Degenerative Mitral Regurgitation in Prohibitive Surgical Risk Patients	84
Early Multinational Experience of Transcatheter Tricuspid Valve Replacement for Treating Severe Tricuspid Regurgitation	83
Transfemoral Tricuspid Valve Replacement in Patients With Tricuspid Regurgitation	83
Patient-Specific Implantation Technique to Obtain Neo-Commissural Alignment With Self-Expanding Transcatheter Aortic Valves	81
Subclinical Leaflet Thrombosis After Transcatheter Aortic Valve Replacement	78
Surgical Explantation After TAVR Failure	78
Contemporary Issues in Chronic Total Occlusion Percutaneous Coronary Intervention	77
Short Duration of DAPT Versus De-Escalation After Percutaneous Coronary Intervention for Acute Coronary Syndromes	76
Suture- or Plug-Based Large-Bore Arteriotomy Closure	76
Cardiopulmonary Hemodynamic Profile Predicts Mortality After Transcatheter Tricuspid Valve Repair in Chronic Heart Failure	76
COAPT-Like Profile Predicts Long-Term Outcomes in Patients With Secondary Mitral Regurgitation Undergoing MitraClip Implantation	75

Racial, Ethnic, and Sex Disparities in Patients With STEMI and Cardiogenic Shock	73
Clinical Outcomes Associated With Left Atrial Appendage Occlusion Versus Direct Oral Anticoagulation in Atrial Fibrillation	73
Risk of Coronary Obstruction Due to Sinus Sequestration in Redo Transcatheter Aortic Valve Replacement	72
Permanent Pacemaker Reduction Using Cusp-Overlapping Projection in TAVR	71
Distal or Traditional Transradial Access Site for Coronary Procedures	68
3- or 1-Month DAPT in Patients at High Bleeding Risk Undergoing Everolimus-Eluting Stent Implantation	68
Coronary Access After TAVR-in-TAVR as Evaluated by Multidetector Computed Tomography	68
Superior Vena Cava Syndrome	68
Right Ventricular Contraction Patterns in Patients Undergoing Transcatheter Tricuspid Valve Repair for Severe Tricuspid Regurgitation	66
6-Month Outcomes of the TricValve System in Patients With Tricuspid Regurgitation	65
Prosthesis-Patient Mismatch After Aortic Valve Replacement in the PARTNER 2 Trial and Registry	63
Preventing Coronary Obstruction During Transcatheter Aortic Valve Replacement	63
Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients With Atrial Fibrillation After TAVR	63
Transcatheter Mitral Valve Replacement	63
Alterra Adaptive Prestent and SAPIEN 3 THV for Congenital Pulmonic Valve Dysfunction	62
Functional Coronary Angiography–Derived Index of Microcirculatory Resistance in Patients With ST-Segment Elevation Myocardial Infarction	61
Half-Dose Direct Oral Anticoagulation Versus Standard Antithrombotic Therapy After Left Atrial Appendage Occlusion	61
Early Feasibility Study of Cardioband Tricuspid System for Functional Tricuspid Regurgitation	60
Distal Versus Conventional Radial Access for Coronary Angiography and Intervention	60
Transcatheter Aortic Valve Replacement With Balloon-Expandable Valves	59
Transcatheter Mitral Valve Repair in Cardiogenic Shock and Mitral Regurgitation	59
Randomized Evaluation of TriGuard 3 Cerebral Embolic Protection After Transcatheter Aortic Valve Replacement	58
Transcatheter Tricuspid Valve Replacement With the EVOQUE System	58
Comparison of Doppler Flow Velocity and Thermodilution Derived Indexes of Coronary Physiology	57
1-Year Outcomes of Fluoropolymer-Based Drug-Eluting Stent in Femoropopliteal Practice	56
Predictors and Clinical Impact of Prosthesis-Patient Mismatch After Self-Expandable TAVR in Small Annuli	55
1-Month Dual-Antiplatelet Therapy Followed by Aspirin Monotherapy After Polymer-Free Drug-Coated Stent Implantation	55
Coronary Artery Fistulas	55
Predicting Periprocedural Complications in Chronic Total Occlusion Percutaneous Coronary Intervention	54
Prospective Study of TMVR Using Balloon-Expandable Aortic Transcatheter Valves in MAC	52
The Impact of Intravascular Ultrasound on Femoropopliteal Artery Endovascular Interventions	52
12-Month Results From the Unblinded Phase of the RADIANCE-HTN SOLO Trial of Ultrasound Renal Denervation	51
Outcomes Following Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement	51
Short-Term Clinical Outcomes of Transcatheter Tricuspid Valve Repair With the Third-Generation MitraClip XTR System	51
Mechanical Circulatory Support as a Bridge to Definitive Treatment in Post-Infarction Ventricular Septal Rupture	51
Impact of Moderate Aortic Stenosis on Long-Term Clinical Outcomes	50
Resuscitation Using ECPR During In-Hospital Cardiac Arrest (RESCUE-IHCA) Mortality Prediction Score and External Validation	50
Procedural and Short-Term Results With the New Watchman FLX Left Atrial Appendage Occlusion Device	50
Peridevice Leak Following Amplatzer Left Atrial Appendage Occlusion	49
Impact of Residual Mitral Regurgitation on Survival After Transcatheter Edge-to-Edge Repair for Secondary Mitral Regurgitation	49
Outcomes of Prosthesis-Patient Mismatch Following Supra-Annular Transcatheter Aortic Valve Replacement	49
30-Day Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement	48
Distal Radial Access	47
Double S-Curve Versus Cusp-Overlap Technique	47
Right Ventricular–Pulmonary Arterial Coupling in Patients With HF Secondary MR	47
Spontaneous Coronary Artery Dissection	47
Long-Term Follow-Up of Hypoattenuated Leaflet Thickening After Transcatheter Aortic Valve Replacement	46
Contemporary Outcomes Following Transcatheter Edge-to-Edge Repair	46
2-Year Outcomes for Transcatheter Repair in Patients With Mitral Regurgitation From the CLASP Study	45
Prospective Evaluation of Transseptal TMVR for Failed Surgical Bioprostheses	44

Improved 3-Year Cardiac Survival After IVUS–Guided Long DES Implantation	44
Outcomes After Transcatheter Aortic Valve Replacement in Bicuspid Versus Tricuspid Anatomy	44
Acute Coronary Tree Thrombosis After Vaccination for COVID-19	44
Randomized Comparison Between Radial and Femoral Large-Bore Access for Complex Percutaneous Coronary Intervention	43
2-Year Outcomes of the Eluvia Drug-Eluting Stent for the Treatment of Complex Femoropopliteal Lesions	43
Explant vs Redo-TAVR After Transcatheter Valve Failure	42
Impact of Intravascular Ultrasound on Long-Term Clinical Outcomes in Patients With Acute Myocardial Infarction	42
Rationale, Definitions, Techniques, and Outcomes of Commissural Alignment in TAVR	42
Balloon-Expandable Valve for Treatment of Evolut Valve Failure	41
Sex Differences in Management and Outcomes of Acute Myocardial Infarction Patients Presenting With Cardiogenic Shock	41
1-Year Results From the RANGER II SFA Randomized Trial of the Ranger Drug-Coated Balloon	41
Defining Percutaneous Coronary Intervention Complexity and Risk	41
Effect of Mitral Valve Gradient After MitraClip on Outcomes in Secondary Mitral Regurgitation	40
TAVR Patients Requiring Anticoagulation	40
Use of Atherectomy During Index Peripheral Vascular Interventions	40
Antithrombotic Therapy After Transcatheter Aortic Valve Replacement	39
Transcatheter Aortic Valve Replacement in Failed Transcatheter Bioprosthetic Valves	39
1-Year Outcomes of Blinded Physiological Assessment of Residual Ischemia After Successful PCI	39
Basics of Coronary Thermodilution	39
Acetylcholine Rechallenge	38
Biodegradable- Versus Durable-Polymer Drug-Eluting Stents for STEMI	38
Balloon-Assisted BASILICA to Facilitate Redo TAVR	38
Association Between Timing of Extracorporeal Membrane Oxygenation and Clinical Outcomes in Refractory Cardiogenic Shock	38
Differential Improvement in Angina and Health-Related Quality of Life After PCI in Focal and Diffuse Coronary Artery Disease	37
Impact of Right Ventricle-Pulmonary Artery Coupling on Clinical Outcomes in the PARTNER 3 Trial	37
Leaflet Configuration and Residual Tricuspid Regurgitation After Transcatheter Edge-to-Edge Tricuspid Repair	37
Clinical Impact of Standardized TAVR Technique and Care Pathway	37
Transcatheter Versus Surgical Aortic Valve Replacement in Young, Low-Risk Patients With Severe Aortic Stenosis	37
Long-Term Clinical Impact of Contrast-Associated Acute Kidney Injury Following PCI	37
Treatment of Coronary De Novo Lesions by a Sirolimus- or Paclitaxel-Coated Balloon	36
Propensity-Matched 1-Year Outcomes Following Transcatheter Aortic Valve Replacement in Low-Risk Bicuspid and Tricuspid Patients	36
The Use and Outcomes of Cerebral Protection Devices for Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement in Clinical Practice	36
Prospective Evaluation of TMVR for Failed Surgical Annuloplasty Rings	36
Effect of Transcatheter Aortic Valve Replacement on Concomitant Mitral Regurgitation and Its Impact on Mortality	36
The PARTNER 3 Bicuspid Registry for Transcatheter Aortic Valve Replacement in Low-Surgical-Risk Patients	35
Stent Expansion Indexes to Predict Clinical Outcomes	35
EROSION III	35
Automated Algorithm Using Pre-Intervention Fractional Flow Reserve Pullback Curve to Predict Post-Intervention Physiological Results	35
Renal Denervation for Hypertension	34
Multicenter Experience With the Transcatheter Leaflet Repair System for Symptomatic Tricuspid Regurgitation	34
Physiological Distribution and Local Severity of Coronary Artery Disease and Outcomes After Percutaneous Coronary Intervention	34
Transcatheter Aortic Valve Replacement With the Latest-Iteration Self-Expanding or Balloon-Expandable Valves	33
Pharmacomechanical Catheter-Directed Thrombolysis With the Bashir Endovascular Catheter for Acute Pulmonary Embolism	33
Unplanned Percutaneous Coronary Revascularization After TAVR	33
Long-Term Outcomes of Patients With Elevated Mitral Valve Pressure Gradient After Mitral Valve Edge-to-Edge Repair	33
Prediction of Death or HF Hospitalization in Patients With Severe FMR	33
Age-Related Outcomes After Transcatheter Aortic Valve Replacement	33
Real-World Outcomes of Fourth-Generation Mitral Transcatheter Repair	33
A Prospective Randomized Trial Comparing Sirolimus-Coated Balloon With Paclitaxel-Coated Balloon in De Novo Small Vessels	32
Prevalence and Predictors of Cardiogenic Shock in Intermediate-Risk Pulmonary Embolism	32
1-Year Outcomes of Cardioband Tricuspid Valve Reconstruction System Early Feasibility Study	32
Prediction of Coronary Stent Underexpansion by Pre-Procedural Intravascular Ultrasound–Based Deep Learning	32
Implications of Periprocedural Myocardial Biomarker Elevations and Commonly Used MI Definitions After Left Main PCI	32
Procedural Characteristics and Late Outcomes of Percutaneous Coronary Intervention in the Workup Pre-TAVR	32
Development and Validation of a Practical Model to Identify Patients at Risk of Bleeding After TAVR	31
Prognostic Links Between OCT-Delineated Coronary Morphologies and Coronary Functional Abnormalities in Patients With INOCA	31
Transcatheter Treatment of Residual Significant Mitral Regurgitation Following TAVR	31
Randomized Controlled Trial of Conventional Versus MicroNet-Covered Stent in Carotid Artery Revascularization	31
Distal vs Conventional Radial Access for Coronary Angiography and/or Intervention	31
Shifting Trends in Timing of Pacemaker Implantation After Transcatheter Aortic Valve Replacement	31
Nationally Representative Repeat Transcatheter Aortic Valve Replacement Outcomes	30
P2Y12 Inhibitor or Aspirin Following Dual Antiplatelet Therapy After Percutaneous Coronary Intervention	30
5-Year Outcomes From the Harmony Native Outflow Tract Early Feasibility Study	30
Intracardiac Echocardiography to Guide Watchman FLX Implantation	30
Apixaban and Valve Thrombosis After Transcatheter Aortic Valve Replacement	30
Optimal Fluoroscopic Projections of Coronary Ostia and Bifurcations Defined by Computed Tomographic Coronary Angiography	30
Prognostic Value of Increased Mitral Valve Gradient After Transcatheter Edge-to-Edge Repair for Primary Mitral Regurgitation	29
Long-Term Outcome of Drug-Coated Balloon vs Drug-Eluting Stent for Small Coronary Vessels	29
Commissural Versus Coronary Optimized Alignment During Transcatheter Aortic Valve Replacement	29
FFR-Guided PCI Optimization Directed by High-Definition IVUS Versus Standard of Care	29
Safety Profile of an Intra-Annular Self-Expanding Transcatheter Aortic Valve and Next-Generation Low-Profile Delivery System	29
Transcaval Versus Transaxillary TAVR in Contemporary Practice	29
Timing, Selection, Modulation, and Duration of P2Y12 Inhibitors for Patients With Acute Coronary Syndromes Undergoing PCI	28
Comparisons of Nonhyperemic Pressure Ratios	28
Cancer Patients Have a Higher Risk of Thrombotic and Ischemic Events After Percutaneous Coronary Intervention	28
Clinical Outcomes at 1 Year Following Transcatheter Left Atrial Appendage Occlusion in the United States	28
Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI	28
Mitral Valve Surgery After Transcatheter Edge-to-Edge Repair	28
Feasibility and Safety of Same-Day Discharge Following Transfemoral Transcatheter Aortic Valve Replacement	28
Functional and Echocardiographic Improvement After Transcatheter Repair for Tricuspid Regurgitation	28

Leaflet and Neoskirt Height in Transcatheter Heart Valves	28
Sex-Related Clinical Characteristics and Outcomes of Patients Undergoing Transcatheter Edge-to-Edge Repair for Secondary Mitral Regurgitation	27
Appropriate Use of Intravascular Ultrasound During Arterial and Venous Lower Extremity Interventions	27
Comparative Safety of Transcatheter LAAO With the First-Generation Watchman and Next-Generation Watchman FLX Devices	27
Impact of Surgical and Transcatheter Aortic Valve Replacement in Low-Gradient Aortic Stenosis	27
Cardiohepatic Syndrome Is Associated With Poor Prognosis in Patients Undergoing Tricuspid Transcatheter Edge-to-Edge Valve Repair	27
Machine Learning Identifies Clinical Parameters to Predict Mortality in Patients Undergoing Transcatheter Mitral Valve Repair	27
Potential Candidates for Transcatheter Tricuspid Valve Intervention After Transcatheter Aortic Valve Replacement	27
Supraventricular Arrhythmia Following Patent Foramen Ovale Percutaneous Closure	27
Combined Pressure and Flow Measurements to Guide Treatment of Coronary Stenoses	27
Differences in Demographics and Outcomes Between Men and Women With Spontaneous Coronary Artery Dissection	26
Patent Foramen Ovale Attributable Cryptogenic Embolism With Thrombophilia Has Higher Risk for Recurrence and Responds to Closure	26
Association of Lipoprotein(a) With Recurrent Ischemic Events Following Percutaneous Coronary Intervention	26
QFR-Based Virtual PCI or Conventional Angiography to Guide PCI	25
5-Year Follow-Up From the PARTNER 2 Aortic Valve-in-Valve Registry for Degenerated Aortic Surgical Bioprostheses	25
The Effect of Coronary Lesion Complexity and Preprocedural Revascularization on 5-Year Outcomes After TAVR	25
Femoral or Radial Approach in Treatment of Coronary Chronic Total Occlusion	25
Pulmonary Artery Denervation for Pulmonary Arterial Hypertension	25
Impact of Eruptive vs Noneruptive Calcified Nodule Morphology on Acute and Long-Term Outcomes After Stenting	25
Association of Acute Procedural Results With Long-Term Outcomes After CTO PCI	25
Transcatheter Versus Rapid-Deployment Aortic Valve Replacement	25
Association of Hospital Procedural Volume With Outcomes of Percutaneous Left Atrial Appendage Occlusion	25
Prophylactic Rivaroxaban Therapy for Left Ventricular Thrombus After Anterior ST-Segment Elevation Myocardial Infarction	25
Target Lesion Failure With Current Drug-Eluting Stents	25
Microvascular Resistance Reserve to Assess Microvascular Dysfunction in ANOCA Patients	24
Access-Site Crossover in Patients With Acute Coronary Syndrome Undergoing Invasive Management	24
Coronary Access Following Redo TAVR	24
Stent Thrombosis Risk Over Time on the Basis of Clinical Presentation and Platelet Reactivity	24
German Multicenter Experience With a New Leaflet-Based Transcatheter Mitral Valve Repair System for Mitral Regurgitation	24
Predictors of Underutilization of Medical Therapy in Patients Undergoing Endovascular Revascularization for Peripheral Artery Disease	24
SCAI/HRS Expert Consensus Statement on Transcatheter Left Atrial Appendage Closure	24
Antithrombotic Management of Elderly Patients With Coronary Artery Disease	24
Operator Volumes and In-Hospital Outcomes	24
Temporal Trends, Practice Variation, and Associated Outcomes With IVUS Use During Peripheral Arterial Intervention	23
Impact of Diabetes on Outcome With Drug-Coated Balloons Versus Drug-Eluting Stents	23
Same-Day Discharge Post–Transcatheter Aortic Valve Replacement During the COVID-19 Pandemic	23
Diagnostic Performance of CCTA and CT-FFR for the Detection of CAD in TAVR Work-Up	23
First-in-Human Dedicated Leaflet Splitting Device for Prevention of Coronary Obstruction in Transcatheter Aortic Valve Replacement	23
Subphenotyping of Patients With Aortic Stenosis by Unsupervised Agglomerative Clustering of Echocardiographic and Hemodynamic Data	23
Transcatheter Aortic Valve Replacement With Self-Expanding ACURATE neo2	23
Redo Surgical Aortic Valve Replacement After Prior Transcatheter Versus Surgical Aortic Valve Replacement	23
Management of Bleeding and Hemolysis During Percutaneous Microaxial Flow Pump Support	23
Clinical Outcomes With Transcatheter Edge-to-Edge Repair in Atrial Functional MR From the EXPAND Study	23
Postoperative Atrial Fibrillation or Flutter Following Transcatheter or Surgical Aortic Valve Replacement	23
Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Complex Coronary Artery Disease	23
Evolution of the Crush Technique for Bifurcation Stenting	22
Peridevice Leak After Transcatheter Left Atrial Appendage Occlusion	22
Feasibility of Coronary Access in Patients With Acute Coronary Syndrome and Previous TAVR	22
Outcomes After Transcatheter Edge-to-Edge Mitral Valve Repair According to Mitral Regurgitation Etiology and Cardiac Remodeling	22
Ischemic Burden Reduction and Long-Term Clinical Outcomes After Chronic Total Occlusion Percutaneous Coronary Intervention	22
10-Year All-Cause Mortality Following Percutaneous or Surgical Revascularization in Patients With Heavy Calcification	22
Clinical Outcomes Following Isolated Transcatheter Tricuspid Valve Repair	22
Clinical Impact of Revascularization Extent in Patients Undergoing Impella-Protected PCI Enrolled in a Nationwide Registry	22
Transcatheter Edge-to-Edge Repair for Atrial Secondary Mitral Regurgitation	22
1-Year Outcomes With Fourth-Generation Mitral Valve Transcatheter Edge-to-Edge Repair From the EXPAND G4 Study	22
Clinical Outcomes in Patients With ST-Segment Elevation MI and No Standard Modifiable Cardiovascular Risk Factors	22
Invasive Coronary Physiology After Stent Implantation	22
Functional Patterns of Coronary Disease	21
Delayed Total Atrioventricular Block After Transcatheter Aortic Valve Replacement Assessed by Implantable Loop Recorders	21
Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents	21
Transcatheter Aortic Valve Replacement for Isolated Aortic Regurgitation Using a New Self-Expanding TAVR System	21
FFR- Versus Angiography-Guided Revascularization for Nonculprit Stenosis in STEMI and Multivessel Disease	21
Improving PCI Outcomes Using Postprocedural Physiology and Intravascular Imaging	21
Treatment of Resistant Hypertension With Endovascular Baroreflex Amplification	21
Clinical Impact of Drug-Coated Balloon–Based Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease	21
MIRACLE2 Score and SCAI Grade to Identify Patients With Out-of-Hospital Cardiac Arrest for Immediate Coronary Angiography	21
Staging Heart Failure Patients With Secondary Mitral Regurgitation Undergoing Transcatheter Edge-to-Edge Repair	21
Safety and Efficacy of Transcatheter Aortic Valve Replacement With Continuation of Vitamin K Antagonists or Direct Oral Anticoagulants	21
Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Prior Mediastinal Radiation	21
Impact of Tricuspid Valve Morphology on Clinical Outcomes After Transcatheter Edge-to-Edge Repair	21
Impact of Transcatheter Edge-to-Edge Mitral Valve Repair on Guideline-Directed Medical Therapy Uptitration	21
Multivessel Versus Culprit-Vessel Percutaneous Coronary Intervention in Patients With Non–ST-Segment Elevation Myocardial Infarction and Cardiogenic Shock	21
Sirolimus-Coated Balloon in an All-Comer Population of Coronary Artery Disease Patients	21
Long-Term Outcomes After PCI or CABG for Left Main Coronary Artery Disease According to Lesion Location	21
Tip-to-Base LAMPOON for Transcatheter Mitral Valve Replacement With a Protected Mitral Annulus	20
Efficacy and Safety of Anticoagulation, Catheter-Directed Thrombolysis, or Systemic Thrombolysis in Acute Pulmonary Embolism	20
Long-Term Outcomes After Atrial Septal Defect Transcatheter Closure by Age and Against Population Controls	20
Technical Considerations for Transcatheter Aortic Valve Replacement With ACURATE neo2	20
Ticagrelor Monotherapy Versus Ticagrelor With Aspirin in Patients With ST-Segment Elevation Myocardial Infarction	20
Coronary Revascularization in Patients Undergoing Aortic Valve Replacement for Severe Aortic Stenosis	20
Transcatheter Aortic Valve Replacement for Pure Native Aortic Valve Regurgitation	20
Assessment of Paclitaxel Drug-Coated Balloon Only Angioplasty in STEMI	20
Evaluating Out-of-Hospital 30-Day Mortality After Transfemoral Transcatheter Aortic Valve Replacement	20
The Association of Chronic Kidney Disease With Outcomes Following Percutaneous Left Atrial Appendage Closure	20
Ultrathin, Biodegradable-Polymer Sirolimus-Eluting Stent vs Thin, Durable-Polymer Everolimus-Eluting Stent	19
Impact of Echocardiographic Guidance on Safety and Efficacy of Left Atrial Appendage Closure	19
Differential Effects of Newer-Generation Ultrathin-Strut Versus Thicker-Strut Drug-Eluting Stents in Chronic and Acute Coronary Syndromes	19
Anatomic Approach to Transseptal Puncture for Structural Heart Interventions	19
Mitral Valve Transcatheter Edge-to-Edge Repair Using MitraClip or PASCAL	19
1-Year Results From a Prospective Experience on CAS Using the CGuard Stent System	19
Neosinus and Sinus Flow After Self-Expanding and Balloon-Expandable Transcatheter Aortic Valve Replacement	19
5-Year Prospective Evaluation of Mitral Valve-in-Valve, Valve-in-Ring, and Valve-in-MAC Outcomes	19
Complete Percutaneous Coronary Revascularization in Acute Coronary Syndromes With Multivessel Coronary Disease	19
Impact of High Implantation of Transcatheter Aortic Valve on Subsequent Conduction Disturbances and Coronary Access	19
5-Year Outcomes With Self-Expanding vs Balloon-Expandable Transcatheter Aortic Valve Replacement in Patients With Small Annuli	19